The action of IGFBP2 in obesity appears to act by both dependent (by modulating IGFs) and independent models (through HBD domains) by directly inhibiting adipogenesis and differentiation of preadipocytes at locally visceral adipose tissue. Here, IGFBP2 is linked to obesity disorder.